AORTIC MOLDING AND OCCLUSION BALLOON CATHETER (MOB)
Report
- Report Number
- 3007284313-2018-00272
- Event Type
- Injury
- Date Received
- September 26, 2018
- Date of Event
- August 29, 2018
- Report Date
- August 19, 2019
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- DQY
- UDI-DI
- 00733132639489
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UT, US
- Reporter Occupation
- PHYSICIAN
Narratives
H10/11: ADDITIONAL MANUFACTURER NARRATIVE/CORRECTED DATA - THIS REPORT IS A FOLLOW UP TO MFR. REPORT # 3007284313-2018-00272 TO INCLUDE THE 510K NUMBER FOR THIS PRODUCT. G5: 510(K) NUMBER: K172567.
ON (B)(6), 2018, THIS PATIENT UNDERWENT ENDOVASCULAR REPAIR OF AN ISOLATED RIGHT COMMON ILIAC ARTERY ANEURYSM USING GORE® EXCLUDER® ILIAC® BRANCH ENDOPROSTHESIS. AFTER THE DEVICE WAS IMPLANTED, AN AORTIC MOLDING AND OCCLUSION BALLOON (MOB) WAS USED FOR BALLOONING AT THE PROXIMAL END. BALLOONING RESULTED IN RUPTURE OF THE RIGHT COMMON ILIAC ARTERY. THE REASON FOR THE RUPTURE WAS NOT REPORTED. A GORE® EXCLUDER® AAA ENDOPROSTHESIS AORTIC EXTENDER COMPONENT WAS IMPLANTED TO TREAT THE RUPTURE. THE RUPTURE WAS SEALED AND THE PATIENT TOLERATED THE PROCEDURE.
.
ON (B)(6) 2018, THIS PATIENT UNDERWENT ENDOVASCULAR REPAIR OF AN ISOLATED RIGHT COMMON ILIAC ARTERY ANEURYSM USING GORE® EXCLUDER® ILIAC® BRANCH ENDOPROSTHESIS. AFTER THE DEVICE WAS IMPLANTED, AN AORTIC MOLDING AND OCCLUSION BALLOON (MOB) WAS USED FOR BALLOONING AT THE PROXIMAL END. BALLOONING RESULTED IN RUPTURE OF THE RIGHT COMMON ILIAC ARTERY. THE REASON FOR THE RUPTURE WAS NOT REPORTED. A GORE® EXCLUDER® AAA ENDOPROSTHESIS AORTIC EXTENDER COMPONENT WAS IMPLANTED TO TREAT THE RUPTURE. THE RUPTURE WAS SEALED AND THE PATIENT TOLERATED THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 749709 | AORTIC MOLDING AND OCCLUSION BALLOON CATHETER (MOB) | CATHETER, PERCUTANEOUS | DQY | W.L. GORE & ASSOCIATES | 18165940 | 00733132639489 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 76 YR | Other| R |